MentalHealthDaily

Caffeine to Prevent Alzheimer’s Disease via Adenosine A2A Receptors? (2023 Review)

by GLOOM

Alzheimer’s Disease (AD), a prevalent form of dementia, poses significant challenges for individuals and healthcare systems worldwide. Current treatments primarily offer symptomatic relief without altering the disease’s progression. However, emerging research suggests that caffeine, a widely consumed psychoactive substance, may have neuroprotective properties against AD. Highlights: Alzheimer’s Disease is the most common form of dementia, …

Olibanum Gum Ineffective for Mild-to-Moderate Alzheimers Disease (2023 Study)

by GLOOM

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline, significantly impacting the elderly. A recent clinical trial investigated the memory-improving potential of Olibanum, a traditional herbal remedy, in AD patients. Highlights: Alzheimer’s disease is a leading cause of dementia, characterized by memory loss and cognitive impairment. Olibanum, also known as Frankincense, has a …

Insulin & Blood Sugar vs. Cognitive Function & Psychiatric Disorders (2023 Evidence)

by GLOOM

Hyperglycemia, or high blood sugar, is more than a mere symptom of diabetes; it’s a complex condition that may significantly impact cognitive functions like memory and attention. While the association between diabetes and physical health complications is well known, there’s a growing body of research exploring how altered insulin signaling, a key feature of diabetes, …

Alzheimer’s Disease, Microglia, & Environmental Risk Factors (2024 Evidence)

by GLOOM

Alzheimer’s disease, a debilitating neurodegenerative condition, is influenced significantly by a blend of genetic, environmental, and lifestyle factors. New research focuses on environmental risk factors and microglia (the brain’s immune cells) for Alzheimer’s development. Highlights: Alzheimer’s Disease and Microglia: Alzheimer’s is characterized by cognitive decline, and microglia play a crucial role in its pathogenesis, acting …

Gene Editing (CRISPR) for Alzheimers Disease Treatment

by GLOOM

Alzheimer’s disease (AD) is an incurable neurodegenerative disease and the most common form of dementia. Research is ongoing to better understand AD pathogenesis and explore potential treatments. Genome editing tools like CRISPR/Cas9 offer new approaches to study and potentially treat AD. Key Facts: AD pathogenesis likely involves multiple genetic and environmental factors Gene mutations linked …

“MIND Diet” Foods May Prevent Alzheimer’s & Age-Related Cognitive Decline

by GLOOM

While people will always be in search of specific diets to help them lose weight, in recent years there is an increasing interest in how certain foods affect the human brain. It is estimated that there are currently over 5 million individuals in the United States that have been diagnosed with Alzheimer’s disease, and dietary …

Namenda (Memantine) Side Effects & Adverse Reactions

by GLOOM

Namenda (Memantine) is a drug that was approved by the FDA in 2003 for the treatment of Alzheimer’s disease. Research suggests that Namenda has a small effect in reducing symptoms among those diagnosed with moderate or severe cases of Alzheimer’s. It appears to have no significant effect when administered to individuals diagnosed with milder cases …